Haugen MH, Lingjærde OC, Garred Ø, Hedenfalk I, Loman N, Mills G, Borresen-Dale AL, Naume B, Mælandsmo GM, Engebråten O (2019)
Design of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients
Ann Oncol, 30 Suppl 3, iii8
DOI 10.1093/annonc/mdz095.022, PubMed 32084915

Svartdal LG, Aure MR, Leivonen SK, Haugen MH, Hongisto V, Kristensen VN, Mælandsmo GM, Sahlberg KK (2019)
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro
Ann Oncol, 30 Suppl 3, iii11
DOI 10.1093/annonc/mdz095.031, PubMed 32084708

Knutsen E, Lellahi SM, Aure MR, Nord S, Fismen S, Larsen KB, Gabriel MT, Hedberg A, Bjørklund SS, Oslo Breast Cancer Research Consortium (OSBREAC), Bofin AM, Mælandsmo GM, Sørlie T, Mortensen ES, Perander M (2020)
The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers
Sci Rep, 10 (1), 1277
DOI 10.1038/s41598-020-57759-4, PubMed 31992741